Literature DB >> 16956786

Infrared and DNA-binding on ultraviolet and fluorescence spectra of new copper and zinc complexes with a naringenin Schiff-base ligand.

Yan-hua Li1, Bao-dui Wang, Zheng-yin Yang.   

Abstract

A naringenin Schiff-base ligand (H(3)L) and its copper(II) and zinc(II) complexes have been synthesized and characterized by elemental analyses, molar conductivities, (1)H NMR, IR spectra, UV spectra and thermal analyses. The DNA-binding properties of the Cu(II) and Zn(II) complexes have been investigated by fluorescence spectroscopy, ultraviolet spectroscopy and by viscosity measurements. The results indicate that complexes and ligand may bind to DNA by intercalation modes, but the binding affinity of the complexes is much higher than that of the ligand.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956786     DOI: 10.1016/j.saa.2006.07.030

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  3 in total

1.  Molecular aspects on the interaction of isatin-3-isonicotinylhydrazone to deoxyribonucleic acid: model for intercalative drug-DNA binding.

Authors:  Soheila Kashanian; Mohammad Mehdi Khodaei; Parvaneh Pakravan; Hadi Adibi
Journal:  Mol Biol Rep       Date:  2011-07-21       Impact factor: 2.742

2.  Study on the Interaction between Isatin-β-Thiosemicarbazone and Calf Thymus DNA by Spectroscopic Techniques.

Authors:  Parvaneh Pakravan; Shahla Masoudian
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

3.  Copper (II) and 2,2'-bipyridine complexation improves chemopreventive effects of naringenin against breast tumor cells.

Authors:  Júlio César Conceição Filho; André Lúcio Franceschini Sarria; Amanda Blanque Becceneri; Angelina Maria Fuzer; Jaqueline Raquel Batalhão; Caio Marcio Paranhos da Silva; Rose Maria Carlos; Paulo Cezar Vieira; João Batista Fernandes; Márcia Regina Cominetti
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.